Search Results 91-100 of 9896 for Clostridioides difficile infection

  1. A Study to Evaluate the Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridium Difficile Infection - Mayo Clinic

    About this study. The purpose of this study is to characterize mucosal and luminal microbiome in patients diagnosed with Clostridium difficile infection ...

  2. Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea - Mayo Clinic

    ... difficile-associated diarrhea (CDAD), which is the primary symptom of recurrent Clostridium difficile infection. All eligible subjects will receive RBX2660 ...

  3. A Study of Changes in the Fecal Microbiome in Patients with Diarrhea without Clostridium difficile Infection - Mayo Clinic

    Clinical Trials · A Study of Changes in the Fecal Microbiome in Patients with Diarrhea without Clostridium difficile Infection · More about research at Mayo ...

  4. Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) In Subjects With Recurrence Of Clostridium Difficile Infection - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of CP101 treatment in adults who had a Clostridum difficile Infection (CDI) recurrence ...

  5. Treatment Of Recurrent Clostridium Difficile Infection With RBX7455 - Mayo Clinic

    ... difficile infection (CDI) in subjects who have had at least one recurrence after a primary episode (i.e., at least two episodes) and have completed at least ...

  6. A Study Using VE303 To Prevent Recurrence Of Clostridium Difficile Infection - Mayo Clinic

    The purpose of this study will evaluate the safety and effectiveness of VE303 for participants with recurrent Clostridium difficile infection (rCDI).

  7. Fecal Microbiota (Stool) Transplant Clinical Trials - Mayo Clinic Research

    ... Clostridioides difficile Infection (CDI) in adult patients. This Phase 3 trial will be conducted in 2 parts: a randomized, double-blind, placebo-controlled ...

  8. Infectious Diseases Clinical Trials - Mayo Clinic Research

    ... Clostridioides difficile Infection (CDI) in adult patients. This Phase 3 trial will be conducted in 2 parts: a randomized, double-blind, placebo-controlled ...

  9. SER-262 Versus Placebo In Adults With Primary Clostridium Difficile Infection To Prevent Recurrence - Mayo Clinic

    ... difficile infection (CDI). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  10. An Extension Of A Previous Study Evaluating The Use Of SER-109 To Prevent Recurrent Clostridium Difficile Infections - Mayo Clinic

    The purpose of this study is to extend the previous SERES-004 study in patients who had a recurrence of clostridium difficile infection within the first 8 weeks ...